Forward P/S Multiple: LENSAR (LNSR)

LENSAR, Inc. - graphic logo of issuer LNSR

LENSAR, Inc. (LNSR) relies on a strategy of precision laser system assembly combined with partial outsourcing of electronics. The forward price-to-sales ratio demonstrates progress toward this goal, while the 1.00 level records fresh values. Revenue is based on the sale of ophthalmic equipment and consumables. However, the pace of clinic upgrades and component supply chain volatility remain headwinds for growth.

lensar.com - LNSR Market Cap to Projected Revenue (period 07/04/2022 - 11/14/2026)

Summary analytical data breakdowns for LENSAR, Inc. (LNSR)

- market price and analyst price targets:
Price Chart LENSAR Inc|LNSR - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization LENSAR Inc|LNSR - Total Enterprise Value
- issuer book value statistics:
Book Value per Share LENSAR|LNSR - Accounting Capitalization|Market Capitalization to Book Value Ratio lensar.com|LNSR - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital LENSAR, Inc.|LNSR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital lensar.com|LNSR - Company Aggregate Debts|Debt to Book Capitalization Ratio LENSAR, Inc.|LNSR - Company Long-Term Debt|Company Current Liabilities LENSAR|Quick Ratio lensar.com
- financial results and valuation multiples details:
LNSR - Company Net Income|Expected Profit LENSAR, Inc.|LNSR - Market Cap to Net Income Ratio|Projected Price to Earnings LENSAR Inc|LNSR - PEG Multiple|EV/EBITDA Multiple LENSAR, Inc|LNSR - Operating income before deduction of amortization|Earnings per share for the last twelve months LENSAR|LNSR - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months lensar.com|LNSR - Net earnings per share growth this year|Earnings growth forecast for next year LENSAR, Inc.
- sales and revenue indicators:
LNSR - Company Total Revenue|Company Projected Revenue LENSAR, Inc.|LNSR - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple LENSAR Inc
Fundamental company analysis:LNSR (LENSAR, Inc)
Product sample of LENSAR Inc

The market valuation of LENSAR, Inc. (LNSR) relative to projected revenue on the company's expected P/S chart reflects current market optimism regarding the adoption rates of laser systems in clinics. This multiple compares market capitalization with future cash flows, allowing investors to determine the asset's degree of overbought status while accounting for electronics supply chain risks and the stability of consumables sales.

Who LENSAR, Inc. competes with

Price-to-Projected Revenue Ratio Dexcom CGM DXCM|Penumbra Corp (PEN) - Market Cap to Future Revenue Ratio|Novanta Inc - Forward P/S Multiple|HAE (Haemonetics Corporation) - Market Cap to Projected Revenue|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED Inc.) - Forward P/S Multiple|Pulse Corp (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward P/S Multiple picardmedical.com (PMI)|Forward P/S Multiple SRDX (surmodics.com)|Forward P/S Multiple Senseonics Holdings, Inc. SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (Sanuwave Health Inc) - Forward Price-to-Revenue Multiple|Projected Price to Revenue Outset Medical OM|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AVITA Medical Inc. RCEL|Price-to-Projected Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Projected Price to Revenue|EDAP TMS SA - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx LUNG|TELA Bio (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corp.)|Price-to-Projected Revenue Ratio sensushealthcare.com|Forward Price-to-Revenue Multiple Zynex, Inc. (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio inspira-technologies.com IINN|Price to Expected Revenue Ratio ICU (SeaStar Medical Holding Corp.)|IRIX: Forward Price-to-Revenue Multiple|ibs.inc - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|Future Price to Revenue PFSA (Profusa Inc.)|Forward Price-to-Revenue Multiple SSKN|Price-to-Projected Revenue Ratio GCTK|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|Venus Concept - Market Cap to Projected Revenue|Forward P/S Multiple NUWE (Nuwellis Corp)|Forward Price to Sales AEMD|ASXC - Price-to-Projected Revenue Ratio|Projected Price to Revenue Avinger, Inc (AVGR)|BSGM: Forward P/S Multiple|Cutera (CUTR) - Forward P/S Multiple|KNW (Know Labs) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Inari Medical (NARI)|Price-to-Projected Revenue Ratio nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical)